Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Buy
26,440
+347
+1% +$40.6K 1.18% 27
2026
Q1
$3.14M Buy
26,093
+348
+1% +$40.2K 1.29% 28
2025
Q4
$2.71M Buy
25,745
+651
+3% +$61.1K 1.08% 32
2025
Q3
$2.11M Sell
25,094
-16,425
-40% -$1.35M 0.86% 42
2025
Q2
$3.29M Sell
41,519
-808
-2% -$64.2K 1.42% 24
2025
Q1
$3.8M Sell
42,327
-412
-1% -$38.5K 1.79% 16
2024
Q4
$4.25M Buy
42,739
+3,299
+8% +$340K 1.89% 14
2024
Q3
$4.48M Sell
39,440
-159
-0.4% -$18.9K 2.04% 14
2024
Q2
$4.9M Buy
39,599
+438
+1% +$56.4K 2.28% 12
2024
Q1
$5.17M Buy
39,161
+139
+0.4% +$17.1K 2.4% 11
2023
Q4
$4.25M Buy
39,022
+621
+2% +$64.5K 2.18% 13
2023
Q3
$3.95M Buy
38,401
+16
+0% +$1.73K 2.24% 11
2023
Q2
$4.43M Sell
38,385
-13,875
-27% -$1.58M 2.39% 11
2023
Q1
$5.56M Buy
52,260
+847
+2% +$91.4K 3.25% 6
2022
Q4
$5.7M Buy
51,413
+832
+2% +$85K 3.63% 5
2022
Q3
$4.36M Sell
50,581
-2,816
-5% -$251K 3.06% 7
2022
Q2
$4.87M Sell
53,397
-381
-0.7% -$33.8K 3.24% 6
2022
Q1
$4.41M Buy
53,778
+1,991
+4% +$157K 2.5% 9
2021
Q4
$3.97M Buy
51,787
+2,395
+5% +$191K 2.17% 10
2021
Q3
$3.71M Buy
49,392
+3,671
+8% +$279K 2.17% 11
2021
Q2
$3.56M Sell
45,721
-248
-0.5% -$18.4K 2.1% 12
2021
Q1
$3.38M Buy
45,969
+4,771
+12% +$352K 2.15% 11
2020
Q4
$3.22M Buy
41,198
+754
+2% +$57.7K 2.23% 11
2020
Q3
$3.2M Sell
40,444
-144
-0.4% -$11.3K 2.6% 9
2020
Q2
$3M Buy
40,588
+22,131
+120% +$1.67M 2.54% 10
2020
Q1
$1.35M Buy
18,457
+293
+2% +$23K 1.41% 27
2019
Q4
$1.58M Buy
+18,164
New +$1.49M 1.31% 31

Other funds holding MRK

Red Spruce Capital's MRK Position: Q2 2026 in Review

Red Spruce Capital increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $40.6K and bringing the position to 26,440 shares worth $3.4M. The position accounts for 1.18% of the portfolio, ranked #27.

Red Spruce Capital first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.7M in Q4 2022. 821 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Red Spruce Capital held 26,440 shares of Merck worth $3.4M as of Q2 2026.
  • Red Spruce Capital bought 347 Merck shares in Q2 2026, an estimated $40.6K.
  • Merck made up 1.18% of Red Spruce Capital's portfolio in Q2 2026, its #27 holding.
  • Red Spruce Capital first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • Red Spruce Capital's Merck position peaked at $5.7M in Q4 2022.
  • 821 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.